CEACAM5 and colorectal cancer: CEA has no value as a stand-alone biomarker for early detection of primary colorectal cancer, but is recommended as a monitoring tool for early detection of disease recurrence allowing for surgical interventions (ASCO, EGTM and NACB recommendations).